Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 CAD | -3.03% | -5.88% | -8.57% |
Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.57% | 29.02M | |
+2.67% | 1.02B | |
-20.72% | 255M | |
-30.78% | 84.44M | |
-33.33% | 51.99M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Interim CEO Agrees to Resign; Mandel Steps in as Interim CEO